Thus, the optoacoustic imaging systems provided herein are useful for diagnosing a pathological or physiological condition characterized by abnormal optical properties of certain volumes of tissues, such as, but not limited to, tumors associated with neoplastic diseases, blood vessels, the heart, hematomas or other tissues containing oxygenated and deoxygenated hemoglobin.